Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.27
+0.43 (6.29%)
At close: Sep 17, 2026, 4:00 PM EDT
7.28
+0.01 (0.14%)
After-hours: Sep 17, 2026, 7:44 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $1.89 billion as of September 17, 2026. Its market cap has increased by 155.80% in one year.
Market Cap
1.89B
Enterprise Value
2.04B
1-Year Change
155.80%
Ranking
Category
Stock Price
$7.27
ChartMarket Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $1.89B, a decrease of -73.89%. That is a compound annual growth rate of -20.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 1.89B | 127.18% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.85B |
| Stoke Therapeutics | 1.82B |
| Septerna | 1.81B |
| Lakefront Biotherapeutics NV | 1.79B |
| Nanobiotix | 1.77B |
| Vir Biotechnology | 1.77B |
| Xencor | 1.77B |
| Tyra Biosciences | 1.75B |